Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins the STAT Innovation Award
Back in the 1990s, scientist Lotte Bjerre Knudsen was tasked with reviving a struggling program at Novo Nordisk that attempted to exploit the newly discovered hormone GLP-1 into possible diabetes drugs. exam. By that time, many of Knudsen’s bosses had lost hope in the program. After all, Novo’s focus is on insulin and the naturally … Read more